Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice
- PMID: 2461007
- DOI: 10.1016/0264-410x(88)90184-3
Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice
Abstract
Protection experiments were performed in mice with different inactivated vaccines prepared with the fixed rabies virus strains: PM (Pitman-Moore), PV4 (Pasteur virus) and LEP (Flury LEP) against an intracerebral challenge with a European bat virus (Duvenhage, strain Hamburg, DUV3). All vaccines protected mice against challenge with CVS (Challenge virus standard). Vaccines prepared with PV4 protected mice against a DUV3 challenge. On the contrary, PM or LEP vaccines did not protect mice against a DUV3 infection. The protection conferred by PV4 vaccines against Duvenhage could be due to the antigenic relationship which seems to exist between PV4 and European bat virus as revealed by serum-virus neutralization, absorption experiments and CTL crossreactivity. The four virus strains PAS, PV4, PM and CVS, originated from the Pasteur virus isolated in 1882 from the brain of a rabid cow, were classified in two groups on the basis of reactivity with neutralizing anti-glycoprotein monoclonal antibodies. One group contained the L. Pasteur (PAS) and the PV4 strains, the second contained PM and CVS strains. The divergence between the two virus groups possibly resulted from distinct passage histories.
Similar articles
-
Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody.J Infect Dis. 1987 Nov;156(5):815-22. doi: 10.1093/infdis/156.5.815. J Infect Dis. 1987. PMID: 3655404
-
Vaccination challenge studies with variants of street rabies virus isolated in Nigeria.Vaccine. 1988 Feb;6(1):19-24. doi: 10.1016/0264-410x(88)90008-4. Vaccine. 1988. PMID: 3354253
-
Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein.J Gen Virol. 1989 Jun;70 ( Pt 6):1513-21. doi: 10.1099/0022-1317-70-6-1513. J Gen Virol. 1989. PMID: 2471814
-
Rabies subunit vaccines.J Gen Virol. 1983 Aug;64 (Pt 8):1649-56. doi: 10.1099/0022-1317-64-8-1649. J Gen Virol. 1983. PMID: 6348210 Review. No abstract available.
-
New vaccines for immunization of man: new approaches towards the prevention of rabies in man.Parassitologia. 1988 Jan-Apr;30(1):141-8. Parassitologia. 1988. PMID: 2478948 Review.
Cited by
-
Chimeric lyssavirus glycoproteins with increased immunological potential.J Virol. 1999 Jan;73(1):225-33. doi: 10.1128/JVI.73.1.225-233.1999. J Virol. 1999. PMID: 9847325 Free PMC article.
-
Genomic and Clinical Analysis of a Fatal Human Lyssavirus irkut Case: Evidence for a Natural Focus in the Russian Far East.Viruses. 2025 May 28;17(6):769. doi: 10.3390/v17060769. Viruses. 2025. PMID: 40573360 Free PMC article.
-
Cross-Protection of Inactivated Rabies Vaccines for Veterinary Use against Bat Lyssaviruses Occurring in Europe.Viruses. 2019 Oct 11;11(10):936. doi: 10.3390/v11100936. Viruses. 2019. PMID: 31614675 Free PMC article.
-
Antigenic and molecular characterization of bat rabies virus in Europe.J Clin Microbiol. 1992 Sep;30(9):2419-26. doi: 10.1128/jcm.30.9.2419-2426.1992. J Clin Microbiol. 1992. PMID: 1401009 Free PMC article.
-
Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity.J Virol. 2001 Apr;75(7):3268-76. doi: 10.1128/JVI.75.7.3268-3276.2001. J Virol. 2001. PMID: 11238853 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous